Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
Background The association between gut bacteria and the response to immune checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC) has been studied; however, multi-kingdom gut microbiome alterations and interactions in ICI-treated HCC cohorts are not fully understood.Methods From November 2018...
Saved in:
| Main Authors: | Longhao Zhang, Shanshan Wang, Yajun Liang, Xiaobo Yang, Haitao Zhao, Xinting Sang, Dongya Zhang, Zhou Lan, Hanping Wang, Ziyu Xun, Chenchen Zhang, Chengpei Zhu, Jiashuo Chao, Zilun Pu, Cong Ning, Xianzhi Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/6/e008686.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer
by: Yang Tan, et al.
Published: (2025-04-01) -
Local–regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study
by: Shuofeng Li, et al.
Published: (2025-07-01) -
Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma
by: Xiaowen Cui, et al.
Published: (2025-06-01) -
POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma
by: Yuan Liang, et al.
Published: (2024-07-01) -
Comprehensive analysis of immune subtype characterization on identification of potential cells and drugs to predict response to immune checkpoint inhibitors for hepatocellular carcinoma
by: Guichuan Lai, et al.
Published: (2025-05-01)